SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer reports 57% rise in Q4 net profit

06 May 2016 Evaluate

Pfizer has reported results for the fourth quarter and year ended March 31, 2016.

The company has posted a rise of 56.91% in its net profit at Rs 66.97 crore for the quarter ended March 31, 2016 as compared to Rs 42.68 crore for the same quarter in the previous year. Total income of the company has increased by 12.78% at Rs 543.44 crore for quarter under review as compared to Rs 481.87 crore for the quarter ended March 31, 2015.

For the year ended March 31, 2016, the company has posted over three fold jump in its net profit at Rs 222.78 crore as compared to Rs 69.82 crore for the same period in the previous year. Total income of company increased 9.48% at Rs 2102.76 crore for year under review as compared to Rs 1920.66 crore for the period ended March 31, 2015.   

Pfizer Share Price

4899.60 8.00 (0.16%)
21-Apr-2026 11:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.50
Dr. Reddys Lab 1221.45
Cipla 1230.00
Zydus Lifesciences 930.90
Lupin 2323.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×